Explore 3 Stock Ideas & Industry Insights Download Free Report

News

ACRO BIOMEDICAL Names New Chairman and CEO in Leadership Shift

ACRO BIOMEDICAL CO. LTD. (OTC: ACBM) changed its senior leadership on September 2, 2026, naming Shao-Hsiang Shih chairman and director and Jing-Zhou Chen chief executive officer and chief financial officer. The appointments took effect the same day, while Yu-Ting Su’s departure from the director, …

Vinay Lochav | 03 September 2026

ACRO BIOMEDICAL Names New Chair, CEO and CFO on Sep 2

New Chairman and Combined Executive Roles

Vinay Lochav | 03 September 2026

Alithya Group Activist Ghyslain Rivard Reports 9.84% Stake

Alithya Group inc (OTC: ALYAF) is subject to an activist ownership position held by Ghyslain Rivard, who is identified with 9.84% of the class. The position concerns Class A subordinate voting shares with no par value. The ownership information is dated 09/02/2026 and identifies …

Vinay Lochav | 03 September 2026

Allurion Technologies Reports 9.99% Beneficial Stake After RTW Assignment

Allurion Technologies, Inc. is subject to a reported 9.99% beneficial ownership position held by RTW Investments, LP and Roderick Wong, M.D. The percentage is calculated using 1,000,416 outstanding common shares, less 392,766 shares surrendered to Allurion in connection with the Share Exchange.

Vinay Lochav | 03 September 2026

NEXT-ChemX Cites India, Pandemic And China-Pakistan Risks In 2024 Report

NEXT-ChemX Corporation recorded a net loss of $2,282,812 for 2024, down $228,201 from 2023.Revenuewas $0 in both periods. At December 31, 2024, the company reported $220,911 in current assets, a working capital deficit of $4,334,788 and an accumulated stockholders’ deficit of $8,794,922.

Vinay Lochav | 03 September 2026

Ollie’s Bargain Outlet (NASDAQ: OLLI) Reports $741M Net Sales, $85.5M Net Income

Basic and diluted earnings per share were each $1.42. The reported period covers the quarter’s operating results and Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI)’s financial position at August 1, 2026.

Vinay Lochav | 03 September 2026

PVH Corp. (NYSE: PVH) Reports Quarterly Loss After Impairment

PVH Corp. (NYSE: PVH) generated revenue of $2,097,000,000 in the quarter, compared with $2,167,200,000 in the comparable period. The quarter produced a net loss, compared with net income in the comparable period.

Vinay Lochav | 03 September 2026

Scribe Therapeutics (NASDAQ: SCTX) Reports June-Quarter Results

Scribe Therapeutics, Inc. (NASDAQ: SCTX) generated $ 1,918,000 in collaboration revenue for the three months ended June 30, 2026, compared with $ 4,898,000 in the comparable period. The company reported a net loss for the three months ended June 30, 2026, compared with a …

Vinay Lochav | 03 September 2026

Southern Cross Acquisition (NASDAQ: SCATU) I Corp. reports $19,738 Quarterly Net Loss

Southern Cross Acquisition I Corp. (NASDAQ: SCATU) posted a net loss of $19,738 for the quarter ended June 30, 2026, with formation and operating costs accounting for the loss. The company had cash of $203,861 at period-end and a working capital deficit of $281,439. …

Vinay Lochav | 03 September 2026

Heberdev I LP Files $97M Exempt Securities Offering

Heberdev I LP is offering $97,000,000 ($97 million) through an exempt securities offering. The notice identifies the entity as an Oil and Gas limited partnership and lists Kevin Patrick Darcy as its chief executive officer.

Vinay Lochav | 03 September 2026
Support

Hi! How can we help you today?

Loading…